People with severely weakened immune systems, such as those infected with HIV, can experience severe symptoms and even die from a monkeypox infection, according to a U.S. study released on Wednesday.
The new frontline of the U.S. abortion battle is on the remote plains of New Mexico, where two conservative towns are set to outlaw the medical procedure despite it remaining legal in the state after Roe v. Wade was struck down.
Lawmakers in Mexico's southern border state of Quintana Roo voted on Tuesday to decriminalize abortion, making it the 11th in a string of states to rewrite their laws after the ban was ruled unconstitutional in 2021.
Pfizer Inc said its fellowship program for minorities serves the public interest, as the drugmaker defends against a lawsuit by a group of medical professionals that claims the program illegally excludes whites and Asian-Americans.
Moderna Inc is nearing a deal with the U.S. government to develop vaccines against a range of biological threats including Ebola, Bloomberg News reported on Wednesday, citing people familiar with the matter.
World Cup host Qatar has scrapped a requirement for visitors to obtain a negative COVID-19 test before departing for the Gulf Arab state, its health ministry said in a statement on Wednesday.
The number of confirmed Ebola cases in Uganda has risen to 109 and the outbreak has claimed 30 lives, Health Minister Jane Ruth Aceng said on Wednesday, adding that the government was setting up an additional treatment centre.
The U.S. Food and Drug Administration has delayed a meeting of its advisory panel to discuss Perrigo Co Plc's over-the-counter (OTC) contraceptive, the drugmaker said on Wednesday.
U.S. doctors are warning that a surge in cases of respiratory syncytial virus (RSV) is coinciding with an increase in COVID transmission and an earlier-than-normal flu season, raising the specter of a "tripledemic" of respiratory illness this winter.
AstraZeneca Plc said on Wednesday its experimental drug capivasertib was able to help patients with an advanced form of breast cancer live longer, when combined with the drugmaker's older cancer treatment Faslodex regardless of biomarker status.
